Aurobindo Pharma, Sandoz Inc call off $900 million deal
newsdepo.com
Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc#39;s US-based generic oral solids and dermatology businesses has been mutually called off.Aurobindo Pharma, Sandoz Inc call off $900 million deal
Aurobindo Pharma on Thursday said the USD 900 million deal to acquire Sandoz Inc#39;s US-based generic oral solids and dermatology businesses has been mutually called off. Read more